Source-grounded facts extracted from Arteris, Inc.'s SEC 8-K filings across all families, newest first. Each cites a verbatim SEC excerpt.
Arteris, Inc. shareholders approved Ratification of the selection of Deloitte & Touche, LLP as the independent registered public accounting firm for fiscal year 2026 at the 2026-06-02 meeting.
“The ratification of the selection by the audit committee of the board of directors of the Company of Deloitte & Touche, LLP as the independent registered public accounting firm of the Company for the fiscal year ending December 31, 2026: Votes For Votes Against Abstentions 36,095,687 145,040 9,284”
Arteris, Inc. shareholders approved Election of three Class II directors to hold office until the 2029 annual meeting at the 2026-06-02 meeting.
“The election of three Class II directors to hold office until the 2029 annual meeting of stockholders or until their respective successor is elected: Nominee Votes For Votes Withheld Broker Non-Votes Antonio J. Viana 24,909,978 8,213,781 3,126,251 Wayne C. Cantwell 26,200,856 6,922,903 3,126,251 Joachim Kunkel 27,178,951 5,944,808 3,126,251”
Arteris, Inc. reported the first quarter ended March 31, 2026 results: revenue $22.9 million, net income $8.0 million or $0.17 per share. Guidance reaffirmed.
“enterprise computing, automotive, communications, industrial automation and aerospace and defense,” concluded Janac. First Quarter 2026 Financial Highlights: • Revenue of $22.9 million, up 39% year-over-year • Trailing-twelve-months variable royalties of $7.9 million, up 67% year-over-year • Annual Contract Value (ACV) plus royalties of $92.8 million, up 39%”
Nick Hawkins departed as Chief Financial Officer at Arteris, Inc..
“Nick Hawkins, Chief Financial Officer of the Company, notified the Company he will retire effective August 31, 2026.”
Arteris, Inc. entered into Agreement and Plan of Merger and Reorganization with Cycuity, Inc. valued at up to $45,000,000 (effective 2025-12-10).
“On December 10, 2025, Arteris, Inc., a Delaware corporation (the “Company”), entered into an Agreement and Plan of Merger and Reorganization (the “Merger Agreement”) with Cabernet Merger Sub I, Inc., a Delaware corporation and wholly-owned subsidiary of the Company (“Merger Sub I”), Arteris Security, LLC, a Delaware limited liability company and wholly-owned subsidiary of the Company (“Merger Sub II”), Cycuity, Inc., a Delaware corporation (“Cycuity”), and Shareholder Representative Services LLC, solely in its capacity as Holder Representative, as defined in the Merger Agreement.”
Isabelle F. Geday resigned as Director at Arteris, Inc..
“On March 25, 2025, Isabelle F. Geday notified the board of directors (the “Board”) of Arteris, Inc. (the “Company”) of her decision to resign from the Board, effective as of March 27, 2025.”
Joachim Kunkel was appointed as Class II director at Arteris, Inc..
“On September 13, 2024, the Board of Directors (the “Board”) of Arteris, Inc. (the “Company”) upon the recommendation of the Nominating and Corporate Governance Committee (“NCG Committee”), approved Joachim Kunkel to be appointed to the Board effective September 16, 2024.”
Arteris, Inc. reported the first quarter ended March 31, 2024 results: revenue $12.9 million, net income $9.4 million or $0.25 per share. Guidance reaffirmed.
“Arteris' continued influence as a leading commercial system IP vendor in the semiconductor industry,” concluded Janac. First Quarter 2024 Financial Highlights: • Revenue of $12.9 million • Annual Contract Value (ACV) and trailing-twelve-months (TTM) variable royalties of $58.2 million , up 6% year-over-year • Remaining performance obligation (RPO) of $74.7”
Arteris, Inc. reported the third quarter ended September 30, 2023 results: revenue $13.3 million, net income $8.2 million or $0.23 per share, EPS $0.23 per share. Guidance initiated.
“Third Quarter 2023 Financial Highlights: • Annual Contract Value (ACV) and Trailing-twelve-month (TTM) variable royalties of $57.3 million, up 8% year-over-year • Revenue of $13.3 million, up 5% year-over-year • Remaining performance obligation (RPO) of $62.5 million • Operating loss of $8.5 million or 63.7% of revenue • Non-GAAP operating loss of $4.5 million or”
Arteris, Inc. reported the quarter ended June 30, 2023 results: revenue $14.7 million, net income Net loss of $9.2 million or $0.26 per share, EPS $0.26 per share. Guidance raised.
“Arteris." Second Quarter 2023 Financial Highlights: • Annual Contract Value (ACV) and Trailing-twelve-month (TTM) royalties of $58.2 million, up 13% year-over-year • Revenue of $14.7 million, exceeding the top end of our guidance • Remaining performance obligation (RPO) of $65.1 million, up $7.8 million sequentially • Operating loss of $8.7 million or 59% of revenue”
Arteris, Inc. shareholders approved Ratification of the selection by the audit committee of the board of directors of the Company of Deloitte & Touche, LLP as the independent registered public accounting firm of the Company for the fiscal year ending December 31, 2023 at the 2023-06-06 meeting.
“Proposal 2 . The ratification of the selection by the audit committee of the board of directors of the Company of Deloitte & Touche, LLP as the independent registered public accounting firm of the Company for the fiscal year ending December 31, 2023: Votes For Votes Against Abstentions 26,887,877 5,741 1,781 As a routine proposal under applicable rules, no broker non-votes were recorded in connection with this proposal.”
Arteris, Inc. shareholders approved Election of two Class II directors to hold office until the 2026 annual meeting of stockholders or until their respective successor is elected at the 2023-06-06 meeting.
“Proposal 1 . The election of two Class II directors to hold office until the 2026 annual meeting of stockholders or until their respective successor is elected: Nominee Votes For Votes Withheld Broker Non-Votes Wayne C. Cantwell 23,595,430 89,614 3,210,355 Antonio J. Viana 20,482,543 3,202,501 3,210,355”
Arteris, Inc. terminated Sale Agreement with Jefferies LLC valued at $50,000,000 (effective 2023-05-04).
“On May 4, 2023, Arteris, Inc. (the “Company”) and Jefferies LLC (“Jefferies”) mutually terminated the Sale Agreement between the parties dated November 8, 2022.”
Arteris, Inc. reported the quarter ended March 31, 2023 results: revenue $13.2 million, net income $9.0 million or $0.26 per share, EPS $0.26 per share. Guidance initiated.
“Janac. First Quarter 2023 Financial Highlights: • Annual Contract Value (ACV) and Trailing-twelve-month (TTM) royalties of $54.8 million, up 4% year-over-year • Revenue of $13.2 million, up 12% year-over-year • Remaining performance obligation (RPO) of $57.3 million • Operating loss of $8.8 million or 67% of revenue • Non-GAAP operating loss of $5.6 million or”
Arteris, Inc. engaged Deloitte & Touche LLP as its auditor.
“On March 23, 2023, the Committee approved the engagement of Deloitte & Touche LLP (“ Deloitte ”) as the Company’s independent registered public accounting firm for the calendar year ending December 31, 2023, effective immediately.”
Arteris, Inc. dismissed Moss Adams LLP as its auditor.
“On March 23, 2023, the Audit Committee (the “ Committee ”) of the Board of Directors of Arteris, Inc. (the “ Company ”) dismissed Moss Adams LLP (“ Moss Adams ”) as the Company’s independent registered public accounting firm, effective immediately.”
Arteris, Inc. updated its full year 2023 guidance (initiated).
“Estimated First Quarter and Full Year 2023 Guidance: Q1 2023 FY 2023 (in millions, except %) ACV + TTM royalties $51.5 - $55.5 $60.4 - $65.4 Revenue $11.0 - $13.0 $56.0 - $60.0 Non-GAAP operating loss (%) 55.0% - 75.0% 28.5% - 43.5% Free cash flow (%) (81.7)% - (56.7)% (19.7)% - (9.7)%”
Arteris, Inc. updated its first quarter 2023 guidance (initiated).
“Estimated First Quarter and Full Year 2023 Guidance: Q1 2023 FY 2023 (in millions, except %) ACV + TTM royalties $51.5 - $55.5 $60.4 - $65.4 Revenue $11.0 - $13.0 $56.0 - $60.0 Non-GAAP operating loss (%) 55.0% - 75.0% 28.5% - 43.5% Free cash flow (%) (81.7)% - (56.7)% (19.7)% - (9.7)%”
Arteris, Inc. reported full year ended December 31, 2022 results: revenue $50.4 million, net income $27.4 million, EPS $0.84 per share.
“Full year 2022 Financial Highlights: • Revenue of $50.4 million, up 33% year-over-yea r • Operating loss of $28.9 million • N on-GAAP operating loss of $16.2 million , compared to a Non-GAAP operating loss of $15.5 million for the year-ended 2021 • Net loss of $27.4 million or $0.84 per share • Non-GAAP net loss of $14.7 million or $0.45 per share • Non-GAAP free cash flow of $(7.8) million or (16)% of revenue”
Arteris, Inc. reported fourth quarter ended December 31, 2022 results: revenue $11.2 million, net income $7.2 million, EPS $0.21 per share.
“Fourth Quarter 2022 Financial Highlights: • Annual Contract Value (ACV) and trailing twelve months (TTM) royalties of $52.4 million, compared to $50.0 million for the same period last year • Revenue of $11.2 million, down 2% year-over-year • Remaining performance obligation (RPO) of $57.7 million, down 5% year-over-year • Operating loss of $9.1 million • Non-GAAP operating loss of $5.8 million , compared to a Non-GAAP operating loss of $2.8 million in the year-ago period • Net loss of $7.2 million or $0.21 per share • Non-GAAP net loss of $4.0 million or $0.12 per share • Non-GAAP free cash flow of $(0.8) million or (7)% of revenue”
Arteris, Inc. reported third quarter ended September 30, 2022 results: revenue $12.6 million, net income Net loss of $7.7 million, EPS $0.23 per share. Guidance initiated.
“IP. ” Third Quarter 2022 Financial Highlights: • Annual Contract Value (ACV) and Trailing-twelve-month (TTM) royalties of $53.2 million, up 17% year-over-year • Revenue of $12.6 million, up 41% year-over-year • Remaining performance obligation (RPO) of $59.3 million, up 17% year-over-year • Operating loss of $7.8 million or 61% of revenue • Non-GAAP operating”
Christian Claussen departed as director at Arteris, Inc..
“Christian Claussen delivered notice of his intention to not stand for reelection to the Board at the Company’s upcoming annual meeting of shareholders”
Claudia Fan Munce was appointed as director at Arteris, Inc..
“appointed Claudia Fan Munce to the Board to fill the vacancy resulting from the increase in the number of authorized directors, with Ms. Munce being appointed to the Board effective May 1, 2022.”
Isabelle Geday changed role as Consultant at Arteris, Inc..
“effective as of December 1, 2021, Isabelle Geday, a member of the Board and a named executive officer, transitioned to a consulting role with the Company and entered into a consulting agreement with the Company.”
Facts are extracted by an LLM and gated to those whose source quote is present verbatim in the filing text. Coverage is best-effort while backfill and monitoring mature; this is not yet a full-market index. See methodology.